RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomy.
Osumi H, Shinozaki E, Suenaga M, Matsusaka S, Konishi T, Akiyoshi T, Fujimoto Y, Nagayama S, Fukunaga Y, Ueno M, Mise Y, Ishizawa T, Inoue Y, Takahashi Y, Saiura A, Uehara H, Mun M, Okumura S, Mizunuma N, Miki Y, Yamaguchi T.
Osumi H, et al.
Int J Cancer. 2016 Aug 15;139(4):803-11. doi: 10.1002/ijc.30106. Epub 2016 Apr 19.
Int J Cancer. 2016.
PMID: 27004837